We have collected information about Paq Insulin Delivery Device for you. Follow the links to find out details on Paq Insulin Delivery Device.
https://www.youtube.com/watch?v=iLefluKzpbk
Feb 17, 2016 · PAQ is a wearable device that delivers up to 3 days of continuous basal insulin plus on-demand mealtime bolus.Author: CeQur
https://clinicaltrials.gov/ct2/show/NCT01535612
The purpose of this study is to evaluate the ability of a patient, who has type 2 diabetes (T2DM) who is currently treated with basal/bolus insulin therapy, to use PaQ™ (a simple patch on insulin delivery device) to control his/her blood glucose.
https://www.prnewswire.com/news-releases/cequr-receives-ce-mark-for-paq-insulin-delivery-device-180978101.html
PaQ is a discreet, wearable device that provides three days of consistent, basal insulin delivery as well as easy, on-demand bolus insulin for individuals with type 2 diabetes.
https://care.diabetesjournals.org/content/37/5/1476
May 01, 2014 · We tested a new, small, and discreet insulin delivery device (PaQ; CeQur SA, Horw, Switzerland) specifically designed for individuals with T2D. PaQ is directly applied to the skin, and insulin is infused at a constant basal rate for 3 days at one of five preset basal rates (Fig. 1A and B).Author: Julia K. Mader, Leslie C. Lilly, Felix Aberer, Stefan Korsatko, Ellie Strock, Roger S. Mazze, Peter ...
News Release . Date: 25 January 2019 ; Published in JDST how CeQur's PAQ Insulin Delivery Device Overcomes Barriers . The Journal of Diabetes Science and Technology paper summarizes data from multiple studies of the PAQ basal-bolus insulin delivery device and how it helps overcome barriers to insulin delivery to meet the needs of people with type 2 diabetes and their healthcare providers.
https://www.drugdeliverybusiness.com/cequr-acquires-wearable-insulin-delivery-device/
Jul 17, 2018 · The Calibra device is a perfect complement to PAQ, our basal and bolus insulin-infusion device. Both wearable devices provide simple, discreet, three-day insulin delivery without the barriers and discomfort created by injections.”
https://diatribe.org/issues/50/new-now-next/5
On November 28, CeQur announced that it had received CE Mark approval for its PaQ Insulin Delivery Device, allowing the product to be sold in Europe.The Swiss-based company has focused on bringing the PaQ device to the European market first, and it has not yet begun the process of securing FDA approval.
https://beyondtype1.org/the-insulin-patch-and-who-will-bring-it-to-market/
The PAQ is similar to the Calibra insulin delivery patch (the device that CeQur has just acquired) in the sense that both of these products are discrete and users can bolus with the touch of a button on the device. However, the PAQ also has 3 days worth of basal insulin, although the rate is fixed. The Calibra insulin delivery system only ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604549/
The PaQ insulin delivery device was designed specifically for individuals with insulin-treated diabetes. In this study of 20 adults with MDI-treated type 2 diabetes, we assessed the impact of PaQ device use on participants’ reported outcomes, regarding barriers to insulin treatment, attitudes toward insulin therapy, and diabetes-related distress.Author: Norbert Hermanns, Leslie C. Lilly, Julia K. Mader, Felix Aberer, Anja Ribitsch, Harald Kojzar, Jay W...
Searching for Paq Insulin Delivery Device?
You can just click the links above. The data is collected for you.
